Advertisement
Singapore markets open in 4 hours 40 minutes

  • Straits Times Index

    3,264.53
    -35.51 (-1.08%)
     

  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     

  • Dow

    39,056.39
    +172.13 (+0.44%)
     

  • Nasdaq

    16,302.76
    -29.80 (-0.18%)
     

  • Bitcoin USD

    61,891.94
    -1,250.51 (-1.98%)
     

  • CMC Crypto 200

    1,320.78
    +26.10 (+2.02%)
     

  • FTSE 100

    8,354.05
    +40.38 (+0.49%)
     

  • Gold

    2,316.30
    -7.90 (-0.34%)
     

  • Crude Oil

    79.21
    +0.83 (+1.06%)
     

  • 10-Yr Bond

    4.4920
    +0.0290 (+0.65%)
     

  • Nikkei

    38,202.37
    -632.73 (-1.63%)
     

  • Hang Seng

    18,313.86
    -165.51 (-0.90%)
     

  • FTSE Bursa Malaysia

    1,604.75
    -0.93 (-0.06%)
     

  • Jakarta Composite Index

    7,088.79
    -34.82 (-0.49%)
     

  • PSE Index

    6,659.18
    +40.60 (+0.61%)
     

This Safe Stock Is Dirt Cheap -- and It's Beating the Market

Alex Carchidi, The Motley Fool
·4-min read
This Safe Stock Is Dirt Cheap -- and It's Beating the Market

The giant French drugmaker Sanofi (NASDAQ: SNY) isn't exactly an obvious candidate for a stock that's likely to beat the market, but its total return of around 8.5% this year is undoubtedly superior to the market's losses of more than 15.4%. Let's take a peek at Sanofi to appreciate why it could be a great pick for the more conservative portion of your holdings. Sanofi sells Dupixent, which treats atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis.

Continue reading